Advances in thyroid orbitopathy

REFERENCES

• Parry CH: Elements Path Ther 2: 111, 1825
   Google Scholar
• Char DH: Thyroid Eye Disease, 2nd edn, New York: Churchill Livingstone, Inc 1990
   Google Scholar
• Bahn RS, Garrity JA, Bartley GB, Gorman CA: Diagnostic evaluation of Graves' ophthalmopathy. Endocrinol Metab Clin NA 17: 527–545, 1988
   PubMed Web of Science ®Google Scholar
• Char DH: The ophthalmopathy of Graves' disease. Med Clin NA 75: 97–119, 1991
   PubMed Web of Science ®Google Scholar
• Coleman DJ, Jack RL, Fransen LA et al: High resolution B-scan ultrasonography of the orbit.. V. Eye changes in Graves' disease. Arch Ophthalmol 88: 465, 1972
   PubMedGoogle Scholar
• Forrester JV, Sutherland JR, McDougall IR: Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography. J Clin Endocrinol Metab 45: 221, 1977
   PubMed Web of Science ®Google Scholar
• Shammas HJ, Minckler DS, Ogden C: Ultrasound in early thyroid orbitopathy. Arch Ophthalmol 98: 277, 1980
   PubMedGoogle Scholar
• Skalka HW: The use of ultrasonography in the diagnosis of endocrine orbitopathy. Neurol Ophthalmol 1: 109, 1980
   Google Scholar
• Werner SC, Coleman DJ, Franzen LA: Ultrasonographic evidence of a consistent orbital involvement in Graves' disease. N Engl J Med 290: 1447, 1974
   PubMed Web of Science ®Google Scholar
• Amino N, Yuasa T, Yabu Y et al: Exophthalmos in autoimmune thyroid disease. J Clin Endocrinol Metab 51: 1232, 1980
   PubMed Web of Science ®Google Scholar
• Wiersinga WM, Smit T, van der Gaag R et al: Clinical presentation of Graves' ophthalmopathy. Ophthalm Res 21: 73, 1989
   PubMed Web of Science ®Google Scholar
• Gorman CA: Temporal relationship between onset of Graves' ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc 58: 515, 1983
   PubMed Web of Science ®Google Scholar
• Solomon DH, Chopra IJ, Chopra U, Smith FJ: Identification of subgroups of euthyroid Graves' ophthalmopathy. N Engl J Med 296: 181–186, 1977
   PubMed Web of Science ®Google Scholar
• Salvi M, Zhang Z-G, Haegert D, Woo M, Liberman A, Cadarso L, Wall JR: Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J Clin Endocrinol Metab 7: 89–94, 1990
   Google Scholar
• Chang TC, Huang KM, Chang TJ, Lin SL: Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease. Clin Endocrinol 32: 551–558, 1990
   PubMed Web of Science ®Google Scholar
• Salvi M, Hiromatsu Y, Bernard N, How J, Wall JR: Pathogenesis of thyroid-associated ophthalmopathy. Dev Ophthalmol 20: 58–67, 1989
   PubMedGoogle Scholar
• Smith TJ, Bahn RS, Gorman CA: Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 10: 366–391, 1989
   PubMed Web of Science ®Google Scholar
• Bahn RS, Gorman CA, Woloschak GE et al: Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. J Clin Endocrinol Metab 65: 665, 1987
   PubMed Web of Science ®Google Scholar
• Rotella CM, Alvarez F, Kohn LD et al: Graves' autoantibodies to extrathyroidal TSH receptor: their role in ophthalmopathy and pretibial myxedema. Acta Endocrinol (suppl) 281: 344, 1987
   Google Scholar
• Rotella CM, Zonefrati R, Toccafondi R et al: Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab 62: 357, 1986
   PubMed Web of Science ®Google Scholar
• Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest F IV: Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. Am J Neuroradiol 7: 651–656, 1986
   PubMed Web of Science ®Google Scholar
• Kahaly G, Schuler M, Sewell AC, Bernhard G, Beyer J, Krause U: Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol 3: 35–44, 1990
   Google Scholar
• Silcock AQ: Case of exophthalmic goiter. Trans Ophthalmol Soc UK 6: 103, 1886
   Google Scholar
• Riley FC Jr: Orbital pathology in Graves' disease. Mayo Clin Proc 47: 975, 1972
   Web of Science ®Google Scholar
• Tallstedt ML, Norberg R: Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophthalmol Vis Sci 29: 175, 1988
   PubMed Web of Science ®Google Scholar
• Prummel MF, Wiersinga WM, Mourits MPh, Koornneef L, Berghout A, van der Gaag R: Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med 150:1098–1101, 1990
   PubMedGoogle Scholar
• Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A: Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321: 1349–1352, 1989
   PubMed Web of Science ®Google Scholar
• Beck RW, DiLoreto DA: Treatment of Graves' ophthalmopathy. N Engl J Med 322: 1088–1089, 1990
   PubMedGoogle Scholar
• Melander A, Nordenskjold E, Lundh B, Thorell J: Influence of smoking on thyroid activity. Acta Med Scand 209: 41, 1981
   PubMedGoogle Scholar
• Bartalena L, Martino E, Marcocci C, Bogazzi F, Panicucci M, Velluzzi F, Loviselli A, Pinchera A: More on smoking habits and Graves' ophthalmopathy. J Endocrinol Invest 12: 733–734, 1989
   PubMed Web of Science ®Google Scholar
• Petersen IA, Kriss JP, McDougall IR, Donaldson SS: Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiation Oncol Biol Phys 19: 259–264, 1990
   PubMed Web of Science ®Google Scholar
• Ridgeway EC: Thyrotropin radioimmunoassays: birth, life and demise. Mayo Clin Proc 63: 1028–1034, 1988
   PubMed Web of Science ®Google Scholar
• Spencer CA: Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clin Proc 63: 1214–1222, 1988
   PubMed Web of Science ®Google Scholar
• Toft AD: Use of sensitive immunoradiometric assay for thyrotropin in clinical practice. Mayo Clin Proc 63: 1035–1042, 1988
   PubMed Web of Science ®Google Scholar
• Utiger RD: Thyrotropin measurements: past, present, future. Mayo Clin Proc 63: 1053–1057, 1988
   PubMed Web of Science ®Google Scholar
• Ehrmann DA, Sarne DH: Serum thyrotropin and assessment of thyroid status. Ann Intern Med 110: 179–181, 1989
   PubMed Web of Science ®Google Scholar
• Singer PA: Clinical approach to thyroid function testing. In: Falk SA (ed): Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine and Radiotherapy, pp 35–47. New York: Raven Press 1990
   Google Scholar
• Morris JC III, Hay ID, Nelson RE, Jiang N-S: Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods. Mayo Clin Proc 63: 707–717, 1988
   PubMed Web of Science ®Google Scholar
• Slamovits TL, Gardner TA: Neuroimaging in neuro-ophthalmology. Ophthalmology 96: 555–568, 1989
   PubMedGoogle Scholar
• Joseph PM, Shetty A: A comparison of selective saturation and selective echo chemical shift imaging techniques. MRI 6: 421–430, 1988
   Google Scholar
• Atlas SW, Grossman RI, Hackney DB, Goldberg HI, Bilaniuk LT, Zimmerman RA: STIR MR imaging of the orbit. Am J Radiol 151: 1025–1030, 1988
   Google Scholar
• Simon JH, Szumowski J: Chemical shift imaging with paramagnetic contrast material enhancement for improved lesion depiction. Radiology 171: 539–543, 1989
   PubMed Web of Science ®Google Scholar
• Char DH: Clinical Ocular Oncology. New York: Churchill-Livingstone 1989
   Google Scholar
• Hosten N, Sander B, Cordes M, Schubert CJ, Schorner W, Felix R: Graves ophthalmopathy: MR imaging of the orbits. Radiology 172: 759–762, 1989
   PubMed Web of Science ®Google Scholar
• Winguth S, Kurhanewicz J, Wang ML, Quivey JM, James TL, Char DH: 31P magnetic resonance spectroscopy (MRS) of experimental orbital myositis. Invest Ophthalmol Vis Sci 32: 2417–2422, 1991
   PubMed Web of Science ®Google Scholar
• Hales IB, Rundle FF: Ocular changes in Graves' disease. Q J Med 29: 113, 1960
   PubMedGoogle Scholar
• Hamilton EH, Schultz RO, DeGowin EL: The endocrine eye lesion in hyperthyroidism. Arch Intern Med 105: 675, 1960
   PubMedGoogle Scholar
• Panzo GJ, Tomsak RL: A retrospective review of 26 cases of dysthyroid optic neuropathy. Am J Ophthalmol 96: 190, 1983
   PubMed Web of Science ®Google Scholar
• Sergott RC, Felberg NT, Savino PJ et al: Graves' ophthalmopathy - immunologic parameters related to corticosteroid therapy. Invest Ophthalmol Vis Sci 20: 173, 1981
   PubMed Web of Science ®Google Scholar
• Sisson JC, Vanderburg JA: Lymphocyte-retrobulbar fibroblast interaction: mechanisms by which stimulation occurs and inhibition of stimulation. Invest Ophthalmol Vis Sci 111: 15, 1972
   Google Scholar
• Prummel MF, Mourits MPh, Berghout A et al: Prednisone and cyclosporin in the treatment of severe Graves' ophthalmopathy. N Engl J Med 321: 1353, 1989
   PubMed Web of Science ®Google Scholar
• Perros P, Weightman DR, Crombie AL, Kendall-Taylor P: Azathioprine in the treatment of thyroid-associated ophthalmopathy. Acta Endocrinol 122: 8–12, 1990
   PubMedGoogle Scholar
• Bartalena L, Marcocci C, Chiovato L et al: Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: a comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 56: 1139, 1983
   PubMed Web of Science ®Google Scholar
• Brennan MW, Leone CR Jr, Janaki L: Radiation therapy for Graves' disease. Am J Ophthalmol 96: 195, 1983
   PubMed Web of Science ®Google Scholar
• Covington EE, Lobes L, Sudarsanam A: Radiation therapy for exophthalmos. Radiology 122: 797, 1977
   PubMed Web of Science ®Google Scholar
• Donaldson SS, Bagshaw MA, Kriss JP: Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 37: 276, 1973
   PubMed Web of Science ®Google Scholar
• Hartemann P, LeClere J, Bey P et al: Le traitement des ophtalmopathies thyroïdiennes par la radiothérapie orbitaire externe. Ann Endocrinol (Paris) 47: 389, 1986
   PubMedGoogle Scholar
• Hurbli T, Char DH, Weaver K et al: Radiation therapy for thyroid ophthalmopathy. Am J Ophthalmol 99: 633, 1985
   PubMed Web of Science ®Google Scholar
• Olivotto IA, Ludgate CM, Allen LH et al: Supervoltage radiotherapy for Graves' ophthalmopathy: CCABC technique and results. Int J Radiat Oncol Biol Phys 11: 2085, 1985
   PubMed Web of Science ®Google Scholar
• Palmer D, Greenberg P, Cornell P et al: Radiation therapy for Graves' ophthalmopathy: a retrospective analysis. Int J Radiat Oncol Biol Phys 13: 1815, 1987
   PubMed Web of Science ®Google Scholar
• Ravin JG, Sisson JC, Knapp WT: Orbital radiation for the ocular changes of Graves' disease. Am J Ophthalmol 79: 285, 1975
   PubMed Web of Science ®Google Scholar
• Teng CS, Crombie AL, Hall R et al: An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy. Clin Endocrinol 13: 545, 1980
   PubMed Web of Science ®Google Scholar
• Van Ouwerkerk VM, Wijngaarde R, Hennemann G et al: Radiotherapy of severe ophthalmic Graves' disease. J Endocrinol Invest 8: 241, 1985
   PubMed Web of Science ®Google Scholar
• Kinyoun JL, Kalina RE, Brower SA et al: Radiation retinopathy following orbital irradiation for Graves' ophthalmopathy [letter]. Arch Ophthalmol 102: 1473, 1984
   PubMedGoogle Scholar
• Parker RG, Withers HR: Radiation retinopathy. JAMA 259: 43, 1988
   PubMed Web of Science ®Google Scholar
• Dandona P, Marshall NJ, Bidey SP et al: Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J 1:374, 1979
   PubMedGoogle Scholar
• Glinoer D: Traitement de I'exophtalmie sévère par l'utilisation de l'échange plasmatique intensif. Rev Méd Brux 7: 379, 1986
   PubMedGoogle Scholar
• Glinoer D, Etienne-Decerf J, Schrooyen M et al: Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Acta Endocrinol 111: 30, 1986
   PubMedGoogle Scholar
• Harden RM, Chisholm CJS, Cant JS: The effect of metronidazole on thyroid function and exophthalmos in man. Metabolism 16: 890, 1967
   Web of Science ®Google Scholar
• Kazeev KN, Zinkevich IV, Karaseva GI et al: Short-term results of parlodel therapy of patients with diffuse toxic goiter complicated by endocrine ophthalmopathy. Probl Endokrinol (Mosk) 33: 3, 1987
   PubMedGoogle Scholar
• Kolodziej-Maciejewska H, Reterski Z: Positive effect of bromocriptine treatment in Graves' disease orbitopathy. Exp Clin Endocrinol 86: 241, 1985
   PubMedGoogle Scholar
• Lopatynsky MO, Krohel GB: Bromocriptine therapy for thyroid ophthalmopathy. Am J Ophthalmol 107: 680, 1989
   PubMed Web of Science ®Google Scholar
• Sawers JS, Irvine WJ, Toft AD et al: Plasma exchange in conjunction with immunosuppressive drug therapy in the treatment of endocrine exophthalmos. J Clin Lab Immunol 6: 245, 1981
   PubMedGoogle Scholar
• Utech C, Wulle KG, Pfannenstiel P et al: Ciamexon-treatment in endocrine ophthalmopathy. Acta Endocrinol (Suppl) 281: 342, 1987
   Google Scholar
• Zesen W, Shubai J, Zutong Z: The effect of acupuncture in 40 cases of endocrine ophthalmopathy. J Trad Chinese Med 5: 19, 1985
   PubMedGoogle Scholar
• Dollinger J: Die Druckentlastung der Augenhoehle durch Entfernung der aeusseren Orbitalwand bei hochgradigem Exophthalmus (Morbus Basedoweii) und konsecutiver Hornhauterkrankung. Dtsch Med Wschr 37: 1888, 1911
   Google Scholar
• Ogura JH, Pratt LL: Transantral decompression for malignant exophthalmos. Otolaryngol Clin N Am 4: 193, 1971
   PubMedGoogle Scholar
• DeSanto LW: The total rehabilitation of Graves' ophthalmopathy. Laryngoscope 90: 1652, 1980
   PubMed Web of Science ®Google Scholar
• McCord CD Jr: Current trends in orbital decompression. Ophthalmology 92: 21, 1985
   PubMed Web of Science ®Google Scholar
• Hurwitz JJ, Birt D: An individualized approach to orbital decompression in Graves' orbitopathy. Arch Ophthalmol 103: 660, 1985
   PubMedGoogle Scholar
• Kennerdell JS, Maroon JC: An orbital decompression for severe dysthyroid, exophthalmos. Ophthalmology 89: 467, 1982
   PubMed Web of Science ®Google Scholar
• Stranc M, West M: A four-wall orbital decompression for dysthyroid orbitopathy. J Neurosurg 68: 671, 1988
   PubMed Web of Science ®Google Scholar
• Kennedy DW, Goodstein ML, Miller NR, Zinreich SJ: Endoscopic transnasal orbital decompression. Arch Otolaryngol Head Neck Surg 116: 275–282, 1990
   PubMedGoogle Scholar
• Mourits MPh, Koornneef L, Van Mourik-Noordenbos AM, Van der Meulen-Schot HM, Prummel MF, Wiersinga WM, Berghout A: Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome? Br J Ophthalmol 74: 481–483, 1990
   PubMed Web of Science ®Google Scholar
• Biglan AW, Bornstine RA, Rogers GC et al: Management of strabismus with botulinum A toxin. Ophthalmology 96: 935, 1989
   PubMed Web of Science ®Google Scholar